Timothy C. Barabe, Director at Opexa Therapeutics, Inc. (OPXA), sold 14,914 shares at $0.55 ($8K) on 2016-11-18, disclosed to the SEC on 2016-11-22.
Open-market sale of $8k OPXA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.55 | 7,105 | $4K | 47.6% |
| 2 | $0.55 | 7,809 | $4K | 52.4% |
| Total | $0.55 avg | 14,914 | $8K | 100% |
| Filing → |
| SELB | BUY | 2022-05-11 | $39K | — | Filing → |
| SELB | BUY | 2021-08-20 | $36K | — | Filing → |
| SELB | BUY | 2021-03-30 | $41K | — | Filing → |